Trial intelligence / Profile preview

Methylphenidate effects on resting-state connectivity in adults with ADHD and healthy controls

NL-OMON39764Withdrawn

Sponsor
University Medical Center Utrecht
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Medical Center Utrecht. Planned start Mar 2013; status: withdrawn.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NL-OMON39764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call